Sunday, April 26, 2009

Updates sent to Twitter, April 19-25

Updates about CSC sent to Twitter during April 19-25:

Geron Presentations on Imetelstat (GRN163L) at the AACR 2009 Annual Meeting [April 23]: http://bit.ly/Ruzqj

Micromet Presents Data at AACR Meeting Showing Elimination of Colorectal Cancer Stem Cells by BiTE Antibody MT110 [April 22]: http://is.gd/tYlI

Physiologic Oxygen Concentration Enhances the Stem-Like Properties of CD133+ Human Glioblastoma Cells In vitro [April 21]: http://bit.ly/QBoo2

How powerful is CD133 as a cancer stem cell marker in brain tumors? [April 21]: http://www.ncbi.nlm.nih.gov/pubmed/19369008

A combination therapy to reduce CSC and stop pancreatic cancer growth? AACR abstract [April 20]: http://www.newswise.com/articles/view/551130/

Possibility raised for new applications of type I interferons to target CSC. [April 19] See: http://dx.doi.org/10.1038/nature07815

Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia [April 19][Archived tweet]: http://www.ncbi.nlm.nih.gov/pubmed/19169242
[See also: Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukemia, Sally Church, Pharma Strategy Blog, March 24, 2009].

No comments:

Post a Comment